Epidemiology, diagnosis, and management of polycystic ovary syndrome

SM Sirmans, KA Pate - Clinical epidemiology, 2013 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common heterogeneous endocrine disorder
characterized by irregular menses, hyperandrogenism, and polycystic ovaries. The …

Diabetes: a metabolic and reproductive disorder in women

EP Thong, E Codner, JSE Laven… - The Lancet Diabetes & …, 2020 - thelancet.com
Reproductive dysfunction is a common but little studied complication of diabetes. The
spectrum of reproductive health problems in diabetes is broad, and encompasses delayed …

Immunological and metabolic causes of infertility in polycystic ovary syndrome

AM Kicińska, RB Maksym, MA Zabielska-Kaczorowska… - Biomedicines, 2023 - mdpi.com
Infertility has been recognized as a civilizational disease. One of the most common causes
of infertility is polycystic ovary syndrome (PCOS). Closely interrelated immunometabolic …

ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes

FH Mahmud, NS Elbarbary… - Pediatric …, 2018 - pmc.ncbi.nlm.nih.gov
• Screening of thyroid function by measurement of thyroid stimulating hormone (TSH) and
antithyroid peroxidase antibodies is recommended at the diagnosis of diabetes (A) and …

Female reproduction and type 1 diabetes: from mechanisms to clinical findings

E Codner, PM Merino… - Human reproduction …, 2012 - academic.oup.com
BACKGROUND The functional reproductive alterations seen in women with type 1 diabetes
(T1D) have changed as therapy has improved. Historically, patients with T1D and insufficient …

Puberty as an accelerator for diabetes complications

YH Cho, ME Craig, KC Donaghue - Pediatric diabetes, 2014 - Wiley Online Library
Much is written about how difficult it is to deal with diabetes during adolescence, and rightly
so. Less is understood as to how puberty may be an accelerator of vascular complications …

Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis

HF Escobar-Morreale, MB Roldán-Martín - Diabetes care, 2016 - diabetesjournals.org
BACKGROUND A few small studies have reported increased prevalences of polycystic
ovary syndrome (PCOS) and symptoms of androgen excess in women with type 1 diabetes …

The relationship between anti-Müllerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome

MJ Chen, WS Yang, CL Chen, MY Wu… - Human …, 2008 - academic.oup.com
BACKGROUND Anti-Müllerian hormone (AMH) is a biomarker that predicts the number of
antral follicles and is involved in follicle arrest for women with polycystic ovary syndrome …

Polycystic ovary syndrome may be an autoimmune disorder

H Mobeen, N Afzal, M Kashif - Scientifica, 2016 - Wiley Online Library
Polycystic ovarian syndrome (PCOS) is the most prevalent endocrine disorder affecting
females. It is a common cause of menstrual irregularities and infertility during reproductive …

[PDF][PDF] Other complications and diabetes-associated conditions in children and adolescents.

O Kordonouri, G Klingensmith, M Knip, RW Holl… - Pediatric …, 2014 - tsi-hannover.de
This article is a chapter in the ISPAD Clinical Practice Consensus Guidelines 2014
Compendium. The complete set of guidelines can be found for free download at www. ispad …